HF
NUVB icon

HRT Financial’s Nuvation Bio NUVB Stock Holding History

HRT Financial’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-631,154
Closed -$2.33M – 3765
2025
Q3 		$2.33M Buy
+631,154
New +$1.72M 0.01% 1058
2024
Q1 		– Sell
-154,066
Closed -$232K – 2844
2023
Q4 		$232K Buy
154,066
+142,247
+1,204% +$183K ﹤0.01% 1732
2023
Q3 		$15K Buy
+11,819
New +$19.7K ﹤0.01% 2092
2023
Q2 		– Sell
-108,463
Closed -$180K – 3004
2023
Q1 		$180K Sell
108,463
-223,492
-67% -$453K ﹤0.01% 1947
2022
Q4 		$637K Buy
+331,955
New +$672K 0.01% 1256
2022
Q3 		– Sell
-41,497
Closed -$134K – 3282
2022
Q2 		$134K Buy
+41,497
New +$181K ﹤0.01% 2364
2021
Q1 		– Sell
-10,879
Closed -$127K – 3014
2020
Q4 		$127K Buy
+10,879
New +$113K ﹤0.01% 1596

Other funds holding NUVB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return

HRT Financial's NUVB Position: Q4 2025 in Review

HRT Financial sold out of Nuvation Bio (NUVB) in Q4 2025, closing a stake of 631,154 shares — an estimated $2.33M sold.

HRT Financial first reported a position in NUVB in Q4 2020 and held it in 7 quarters. The position peaked at $2.33M in Q3 2025. 223 funds tracked by Wall St. Rank hold NUVB as of Q4 2025.

  • HRT Financial reported no remaining Nuvation Bio position as of Q4 2025 after selling out during the quarter.
  • HRT Financial sold 631,154 Nuvation Bio shares in Q4 2025, an estimated $2.33M.
  • HRT Financial first reported a position in Nuvation Bio in Q4 2020 and held it in 7 quarters.
  • HRT Financial's Nuvation Bio position peaked at $2.33M in Q3 2025.
  • 223 funds tracked by Wall St. Rank held Nuvation Bio as of Q4 2025.

Based on HRT Financial's 13F filing for Q4 2025, filed 12 Feb 2026.